Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Paolini John F. Create: Alert

All | News | Filings
Date FiledTypeDescription
07/27/2023 4 Paolini John F. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Sold 5,200 shares @ $18.01, valued at $93.7k
Sold 16,168 shares @ $19.25, valued at $311.2k
Sold 7,632 shares @ $19.69, valued at $150.3k
Exercised 29,000 options to buy @ $1.86, valued at $53.9k
07/25/2023 144 Form 144 - Report of proposed sale of securities:
04/03/2023 4 Paolini John F. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 38,974 options to buy @ $10.76, valued at $419.4k
Granted 6,496 options to buy @ $0
03/20/2023 4 Paolini John F. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Paid exercise price by delivering 507 shares @ $11.46, valued at $5.8k
Paid exercise price by delivering 1,078 shares @ $11.12, valued at $12k
Exercised 1,725 options to buy @ $0
Exercised 3,671 options to buy @ $0
11/09/2022 4 Paolini John F. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Sold 28,357 shares @ $15.18, valued at $430.5k
Exercised 28,357 options to buy @ $1.86, valued at $52.7k
09/06/2022 4 Paolini John F. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Paid exercise price by delivering 507 shares @ $11.44, valued at $5.8k
Granted 59,930 options to buy @ $11.97, valued at $717.4k
Granted 9,990 options to buy @ $0
Exercised 1,725 options to buy @ $0
04/11/2022 4 Paolini John F. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 59,930 options to buy @ $11.1, valued at $665.2k
Granted 9,990 options to buy @ $0
03/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/14/2020 4 Paolini John F. (SVP & Chief Medical Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 50,000 options to buy @ $15.5, valued at $775k
03/17/2020 4 Paolini John F. (SVP & Chief Medical Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 50,000 options to buy @ $15.52, valued at $776k
03/02/2020 4 Paolini John F. (SVP & Chief Medical Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Exercised 12,000 options to buy @ $1.86, valued at $22.3k
02/21/2020 4 Paolini John F. (SVP & Chief Medical Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Sold 22,477 shares @ $18.27, valued at $410.7k
Sold 8,687 shares @ $18.91, valued at $164.3k
Sold 1,116 shares @ $19.32, valued at $21.6k
Exercised 22,477 options to buy @ $3.8, valued at $85.4k
Exercised 9,803 options to buy @ $3.8, valued at $37.3k
02/18/2020 4 Paolini John F. (SVP & Chief Medical Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Sold 10,277 shares @ $18.29, valued at $188k
Sold 1,039 shares @ $18.33, valued at $19k
Exercised 10,277 options to buy @ $3.8, valued at $39.1k
Exercised 1,039 options to buy @ $3.8, valued at $3.9k
12/09/2019 4 Paolini John F. (SVP & Chief Medical Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Exercised 8,000 options to buy @ $1.86, valued at $14.9k
10/09/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/19/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/06/2019 4 Paolini John F. (SVP & Chief Medical Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 51,000 options to buy @ $17.92, valued at $913.9k
09/24/2018 4 Paolini John F. (SVP & Chief Medical Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 45,000 options to buy @ $30.93, valued at $1.4M
05/23/2018 3 Paolini John (Chief Medical Officer) has filed a Form 3 on Kiniksa Pharmaceuticals, Ltd.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy